News

July 26, 2010
IDENIX PHARMACEUTICALS REPORTS SECOND QUARTER 2010 FINANCIAL RESULTS AND PROVIDES RESEARCH AND DEVELOPMENT UPDATE ON HCV PROGRAMS

July 14, 2010
Evotec Strengthens Discovery Alliance Business Through Acquisition of DeveloGen

July 09, 2010
Nabriva initiates Phase II of pleuromutilin antibiotic BC-3781

June 17, 2010
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics

April 16, 2010
Idenix Pharmaceuticals Reports Favourable Pharmacokinetic Data for IDX320, A Potent, Multi-Genotypic Protease Inhibitor For The Treatment of Hepatitis C

April 15, 2010
Idenix Pharmaceuticals Reports Positive Results With IDX184 From Interim Analysis of Phase IIa Hepatitis C Study

April 12, 2010
Nabriva Reports Successful Phase I Clinical Trial For BC-3781

Jan 11, 2010
Idenix Pharmaceuticals Highlights Progress In Three HCV Programs

December 3, 2009
AstraZeneca and Targacept Form Global Collaboration and License Agreement for Late-stage Investigational Product TC-5214 for the Treatment of Major Depressive Disorder

December 2, 2009
Phenomix Grants Chiesi Farmaceutici European Rights to Dutogliptin for Diabetes

November 9, 2009
Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of Its ZP PTH Patch For Osteoporosis Therapy

October 28, 2009
Nabriva Therapeutics raises Euro 15 Million (USD22 Million) 

October 12, 2009
Proteolix, Inc To Be Acquired by Onyx Pharmaceuticals

October 8, 2009
Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3

July 20, 2009
Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 For The Treatment of Hepatitis C Virus (HCV) 

July 15, 2009
Targacept's TC-5214 Achieves All Primary and Secondary Outcome Measures in Phase 2b Trial as Augmentation Treatment for Major Depressive Disorder 

June 23, 2009
GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs 

June 23, 2009
Chroma Therapeutics Completes £15 Million Series D Financing 

May 13, 2009
Boehringer Ingelheim and DeveloGen AG announce agreement in the field of diabetes, obesity and the metabolic syndrome

May 11, 2009
Targacept Announces Positive Top-Line Results from Phase II Study of AZD3480 in Adult ADHD

May 7, 2009
Nabriva Therapeutics Appoints New Supervisory Board Member 

May 4, 2009
ACADIA Pharmaceuticals and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in North America

April 23, 2009
Idenix Pharmaceuticals Reports Data from Three Hepatitis C Development Programs

March 25, 2009
Acadia Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs

February 26, 2009
DeveloGen Reports Positive Phase 1 Clinical Trial Results for DG3173

February 25, 2009
Proteolix Announces the Appointment of John Scarlett, MD, President and CEO

February 6, 2009
Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, A Novel NNRTI for the Treatment of HIV

January 28, 2009
Nomura Phase4 Ventures named Venture Capital House of the Year 

December 9, 2008
Proteolix Announces Positive Data from Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma

November 4, 2008
OncoMed Pharmaceuticals Completes Series B Financing; Lead Cancer Stem Cell Product Enters Clinical Trials

October 30, 2008
Top City Women Scoop Prestigious Awards

October 23, 2008
Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes

September 12, 2008
Ominsonics Medical Technologies Announces Licensing and Development Agreement with Boston Scientific

September 11, 2008
Zosano Pharma, Inc. Announces Positive Results of Phase 2 Trial with PTH Transdermal Patch in Osteoporosis

September 11, 2008
Cerimon Pharmaceuticals Announces Positive Results from a PhaseII Clinical Study of its Diclofenac Sodium Patch for Acute Pain

September 8, 2008
Proteolix Raises $79 Million in Series C Financing

September 8, 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO

September 4, 2008
Idenix Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naïve HIV-Infected Patients

June 17, 2008
Families of Spinal Muscular Atrophy and Paratek Pharmaceuticals Extend and Expand Drug Discovery Collaboration for Spinal Muscular Atrophy

June 17, 2008
ARYx Therapeutics Inc Commences Phase2/3 Clinical Trial on Oral Anticoagulant Agent ATI-5923 - EmbraceAC Comparative Study Against Leading Anticoagulant Warfarin

July 7, 2008
Nabriva Therapeutics Announces Appointment of George Golumbeski as CEO

June 12, 2008
Idenix Announces Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naïve HIV-Infected Patients

May 22, 2008
Altus Pharmaceuticals Appoints Georges Gemayel Chief Executive Officer and Member of Board of Directors

May 16, 2008
Phenomix Announces PHX1149 Phase2b Clinical Trial Results for Type 2 Diabetes

May 7, 2008
Albireo Announces Second Closing of Series A Financing

April 16, 2008
Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections

March 31, 2008
ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis

March 24, 2008
Nomura Phase4 Ventures' Feature in BioCentury: Clear route to Phase IIb

February 14, 2008
Nomura Phase4 Ventures leads spin out of Albireo from AstraZeneca, raising up to US$40 in Series A equity financing

February 6, 2008
IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a PhaseI/II Clinical Trial in Treatment Naive HIV-Infected Patients

January 25, 2008
Phenomix Files Registration Statement For Proposed Initial Public Offering

January 16, 2008
Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate Its Diclofenac Patch for Mild to Moderate Pain

January 7, 2008
Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline

December 19, 2007
Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialization Rights

December 13, 2007
Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797

December 3, 2007
Targacept Announces Results of Phase II Study of TC-2696 in Postoperative Dental Pain

November 15, 2007
PerkinElmer Completes Acquisition of Viacell

November 15, 2007
Zosano Pharma Announces Funding Close Totaling $90 Million

November 7, 2007
ARYx Therapeutics Announces Pricing of its Initial Public Offering

November 5, 2007
Targacept to Receive $2 Million from AstraZeneca for Option to Lead Product Candidate in Alpha7 NNR Program

October 25, 2007
Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections

October 8, 2007
OmniSonics Announces that FDA Clears OmniWave endovascular system for clot removal in peripheral vessels

October 1, 2007
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell

September 28, 2007
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs

September 27, 2007
Macroflux Announces Name Change to Zosano Pharma, Inc.

September 20, 2007
Viacell Announces that Children Can be Cured of Sickle Cell Disease and Thalassemia After Sibling Cord Blood Transplantation

September 18, 2007
ViaCell Announces Expansion of ViaCord Processing Laboratory

September 4, 2007
ViaCell Announces ViaCyte Collaboration with EMD Serono, Inc.

August 30, 2007
ARYx Therapeutics Files Registration Statement for Initial Public Offering

August 14, 2007
Nabriva Announces the Initiation of Clinical Phase1 Study for Topical Antibiotic.

August 14, 2007
Altus Pharmaceuticals' ALTU-237 Enters Phase I Clinical Trial for the Treatment of Hyperoxalurias and the Potential Prevention of Kidney Stone Formation.

July 27, 2007
Targacept and GlaxoSmithKline Form Alliance in Therapeutics for CNS-related Disorders.

July 16, 2007
ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate.

July 13, 2007
Idenix's Valopicitabine Development Program Placed on Clinical Hold in the United States.

July 9, 2007
Paratek Pharmaceuticals and Warner Chilcott Sign Collaboration Agreement for Novel, Narrow-Spectrum Agents for Acne and Rosacea.

March 8, 2007
Nomura Phase4 Ventures leads a US$55 million Series C equity financing of Phenomix Corporation.